Phoenix Biotech
 | |
| Trading name | Phoenix Biotech |
|---|---|
| Type | Pharmaceutical Biotech |
| Industry |
|
| Founded | 1632 AN |
| Headquarters | Stonewall, Wrighthaven, Ciric Confederacy |
| Key people | Balak Azir |
Phoenix Biotech is a biotechnology, pharmaceutical development, and genetic engineering company based and registered in the Ciric Confederacy, and is a subsidiary company of the Andromeda Tech Corporation. The company is the largest company of its type, including specialised companies of pharmaceutical or genetic engineering nature, in the confederacy, and distributes its products to a global market through the Andromeda online marketplace.
Phoenix Biotech is most commonly known for its pharmaceutical products, including its most sold product known as "Victis", which is an immunostimulator used to prevent bacterial infections in patients undergoing chemotherapy treatment for cancer. Phoenix Biotech has also quickly developed a market for its newest product very quickly; known as "Invictus", the product is meant to be taken by cancer patients to slow (or, in some cases, entirely prevent) the metastasis of certain types of cancer, including stomach cancer, liver cancer, pancreatic cancer, lung cancer, brain cancer, and leukemia.
These are accomplished by the usage of programmed viruses that can "scan" normal cells of the type affected by the cancer in order to eradicate cellular aberrations, which includes the cancerous cells. This implementation of genetic scanning and programmable virus technology has also contributed to the development of what Phoenix genetic researchers have dubbed the "Nephilim Gene Template", which is a modification to the standard human genome that has shown in tests to cause newborn children with the template to have a 94% lower chance to be affected by allergies, and are 23% more resistant to bacterial infection. Other benefits from the template are being monitored as the test subjects progress through their lives (including susceptibility to cancer and degenerative diseases), but Phoenix has collaborated with Andromeda Health to offer the template to pregnant mothers for their children for free, ostensibly to function as an additional batch of test subjects, but also to spread the word of the template in general. Research has been initiated into possibilities of applying the template to mature individuals, as well as into a more sophisticated version with the working name of the "Cherubim Gene Template", that will lower the chances of infection and disease even lower, as well as give engineers more precise control over the displaying phenotype.
